High-dose erythropoietin (EPO; a hormone) administered within 42 hours of birth to preterm infants was associated with a reduced risk of brain injury, as indicated by magnetic resonance imaging (MRI). This is according to a study in the August 27 issue of iJAMA/i. Survival of premature infants has improved over the past decades, but at the expense of an increase in the number of infants affected by long-term developmental disabilities. Premature infants are ...
Read More
You have just read an article categorized health
titled EPO Associated With Reduced Risk of Brain Abnormalities in Preterm Infants.
Written by:
editor -
Saturday, August 30, 2014
There are currently no comments for "EPO Associated With Reduced Risk of Brain Abnormalities in Preterm Infants"
Post a Comment